SPRY logo
ARS Pharmaceuticals, Inc.(SPRY)
Last print unknown agoAbout this dataData status
$4.23▲0.21 (5.22%)Stale · unknown old

SPRY Investing Cash Flow

$48.50MTTM · USD

Period ending:

SPRY FY Cash from InvestingUSD
SPRY FY Cash from Investing2018-12-31: -$449.00K2019-12-31: -$96.00K2020-12-31: -$917.00K2021-12-31: -$55.00K2022-12-31: -$199.00K2023-12-31: -$87.18M2024-12-31: -$106.10M2025-12-31: $56.77M$56.77M-$106.10M
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SPRY investing cash flow history

Cash used for investments in assets and securities. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Ars Pharmaceuticals Inc Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
56,768,000
-106,101,000
-87,180,000
-199,000
-55,000
-917,000
-96,000
-449,000

Compare investing cash flow

All SPRY financial metrics · SPRY stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.